reticulin has been researched along with Autoimmune Thrombocytopenia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cines, D; Giagounidis, A; Godeau, B; Liebman, H; Pabinger, I; Rodeghiero, F; Stasi, R; Viallard, JF; Wang, X; Woodard, P | 1 |
| Bailey, CK; Bakshi, KK; Brynes, RK; Burgess, P; Orazi, A; Thein, MM; Theodore, D | 1 |
| Anderson, D; Boda, Z; Červinek, L; Chong, BH; Franklin, J; Janssens, A; Pabinger, I; Rodeghiero, F; Terrell, DR; Wang, X | 1 |
| Bakshi, KK; Brynes, RK; Burgess, P; Orazi, A; Thein, MM; Theodore, D; Wong, RS | 1 |
| Bain, BJ; Davis, W; Hasserjian, RP; Kuter, DJ; Mufti, GJ; Rutstein, M | 1 |
| Cha, S; Engebjerg, MC; Ettrup, MS; Farkas, DK; Jensen, AØ; Johansen, P; Nørgaard, M; Sørensen, HT; Zhao, S | 1 |
| Leung, T; Lokan, J; Smith, C; Turner, P | 1 |
| Arabadjief, M; Boiocchi, L; Bussel, JB; Geyer, JT; Ghanima, W; Orazi, A | 1 |
| Boiocchi, L; Bussel, JB; Feng, X; Geyer, JT; Ghanima, W; Gudbrandsdottir, S; Hasselbalch, HC; Junker, P; Orazi, A | 1 |
1 review(s) available for reticulin and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.
Topics: Adult; Aged; Child; Clinical Trials as Topic; Humans; Intracranial Hemorrhages; Middle Aged; Platelet Count; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Reticulin; Thrombopoietin; Thrombosis; Treatment Outcome | 2013 |
4 trial(s) available for reticulin and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Evaluation of bone marrow reticulin in patients with chronic immune thrombocytopenia treated with eltrombopag: Data from the EXTEND study.
Topics: Adult; Benzoates; Bone Marrow; Bone Marrow Examination; Chronic Disease; Female; Follow-Up Studies; Humans; Hydrazines; Male; Middle Aged; Platelet Count; Primary Myelofibrosis; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Thrombopoietin; Reticulin | 2015 |
Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia.
Topics: Adult; Aged; Bone Marrow; Cohort Studies; Collagen; Female; Humans; Male; Middle Aged; Platelet Count; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Receptors, Fc; Recombinant Fusion Proteins; Reticulin; Thrombopoietin; Treatment Outcome | 2016 |
A 2-Year, Longitudinal, Prospective Study of the Effects of Eltrombopag on Bone Marrow in Patients with Chronic Immune Thrombocytopenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzoates; Biopsy; Bone Marrow; Chronic Disease; Collagen; Female; Humans; Hydrazines; Male; Middle Aged; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Reticulin | 2017 |
Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim.
Topics: Adult; Animals; Bone Marrow; Carrier Proteins; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Rats; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Reticulin; Retrospective Studies; Thrombopoietin | 2009 |
4 other study(ies) available for reticulin and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Bone marrow reticulin and collagen content in patients with adult chronic immune thrombocytopenic purpura: a Danish nationwide study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Bone Marrow; Collagen; Denmark; Female; Fibrosis; Humans; Male; Middle Aged; Prevalence; Purpura, Thrombocytopenic, Idiopathic; Reticulin; Retrospective Studies; Sex Factors; Young Adult | 2010 |
Reversible bone marrow reticulin fibrosis as a side effect of romiplostim therapy for the treatment of chronic refractory immune thrombocytopenia.
Topics: Aged; Bone Marrow; Drug Resistance; Fibrosis; Humans; Immunosuppressive Agents; Male; Purpura, Thrombocytopenic, Idiopathic; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Recovery of Function; Reticulin; Thrombopoietin | 2011 |
Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities.
Topics: Adolescent; Adult; Aged; Biomarkers; Biopsy; Bone Marrow Cells; Bone Marrow Examination; Child, Preschool; Extracellular Matrix Proteins; Female; Humans; Immunohistochemistry; Immunologic Factors; Male; Megakaryocytes; Middle Aged; Primary Myelofibrosis; Purpura, Thrombocytopenic, Idiopathic; Receptors, Thrombopoietin; Reticulin; Stromal Cells; Time Factors; Treatment Outcome | 2012 |
Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents.
Topics: Adult; Benzoates; Bone Marrow; Combined Modality Therapy; Cytokines; Female; Hepatocyte Growth Factor; Humans; Hydrazines; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Peptide Fragments; Primary Myelofibrosis; Procollagen; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Reticulin; Splenectomy; Thrombopoietin | 2011 |